Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leprosy research and elimination.

S K Noordeen

    Leprosy Review
    |February 24, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Leprosy research, particularly through WHO initiatives, has been crucial for disease control. Multi-drug therapy (MDT) significantly reduced leprosy prevalence, though nerve damage requires further investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Eliminating Leprosy in India--Is it a Dream?

    Indian journal of leprosy·2016
    Same author

    Obituary--Dr. Jacinto Convit.

    Leprosy review·2014
    Same author

    Role of dermatologists in leprosy.

    Leprosy review·2007
    Same author

    Case-detection trends in leprosy and factors influencing them.

    Indian journal of leprosy·2006
    Same author

    Welcome address by S.K. Noordeen. National Conference on Elimination of Leprosy.

    Indian journal of leprosy·2005
    Same author

    Vision beyond 2005.

    Indian journal of leprosy·2005

    Area of Science:

    • Tropical medicine
    • Infectious disease research
    • Public health

    Background:

    • Leprosy research has been vital for disease elimination efforts.
    • The World Health Organization's Special Programme for Research and Training in Tropical Diseases (TDR) significantly advanced leprosy research.
    • Two key scientific working groups, the Immunology of Leprosy (IMMLEP) and Chemotherapy of Leprosy (THELEP), were established in 1974 and 1976, respectively.

    Purpose of the Study:

    • To evaluate the contribution of organized leprosy research initiatives to disease control and elimination.
    • To assess the impact of scientific working groups on research direction and outcomes.
    • To review progress in developing leprosy vaccines and improved drug therapies.

    Main Methods:

    • Review of historical initiatives and research programs.

    Related Experiment Videos

  • Analysis of the impact of the WHO Special Programme for Research and Training in Tropical Diseases (TDR), IMMLEP, and THELEP.
  • Evaluation of the development and efficacy of leprosy vaccines and multi-drug therapy (MDT).

    • Main Results:

    • Coordinated research efforts facilitated by IMMLEP and THELEP led to advancements in leprosy treatment and vaccine development.
    • Initial prospects for a leprosy vaccine were high but ultimately unmet due to technical challenges and decreasing disease incidence.
    • The development and introduction of multi-drug therapy (MDT) are credited with the significant global reduction in leprosy cases.

    Conclusions:

    • Multi-drug therapy (MDT) has been the primary driver of progress in controlling leprosy as a public health problem.
    • While vaccine development faced setbacks, ongoing research is still needed for areas like managing nerve damage in leprosy patients.
    • Continued research investment is essential to address remaining challenges and achieve complete leprosy elimination.